PARP inhibitors alone or in combination for prostate cancer
MD Fenor de la Maza, JL Pérez Gracia… - Therapeutic …, 2024 - journals.sagepub.com
DNA repair genomic aberrations in the Homologous Recombination pathway are
identifiable in up to 25% of patients with advanced prostate cancer, making them more likely …
identifiable in up to 25% of patients with advanced prostate cancer, making them more likely …
[HTML][HTML] Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous …
D Olmos, D Lorente, D Alameda, C Cattrini… - Annals of …, 2024 - Elsevier
Background Although germline BRCA mutations have been associated with adverse
outcomes in prostate cancer (PC), understanding of the association between …
outcomes in prostate cancer (PC), understanding of the association between …